The director of the University of Pittsburgh’s Autism Center of Excellence talks about her new work investigating suicidality in autistic adults.
SourceSource: Spectrum News
The newfound DNA-cutting enzyme, called Fanzor, can be programmed to edit the human genome and could prove easier to deliver to cells than current CRISPR tools.
SourceSource: Spectrum News
The New York State Psychiatric Institute in New York City is undergoing an audit and a change in leadership following a suicide that occurred during one of its clinical trials.
SourceSource: Spectrum News
This month’s Going on Trial newsletter explores how organ-on-a-chip models could smooth the transition from preclinical to clinical trials, among other drug development news.
SourceSource: Spectrum News
This week on social media, researchers discussed research on sensory issues in fragile X mice, and they considered yet another study of epidurals and autism. That and more in this week’s Community Newsletter.
SourceSource: Spectrum News
A new resource gives an unparalleled look at how fetal placental cells attach to the uterine wall and remodel maternal blood vessels to access nutrients.
SourceSource: Spectrum News
A speech-language pathologist by training, Wetherby has spent more than four decades developing tools to help identify and treat autism early; now her work has taken on a more personal sense of urgency.
SourceSource: Spectrum News
The mutation increases the activity of an autism-linked protein and leads to social difficulties and other behavior differences in mice.
SourceSource: Spectrum News